ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disability"

  • Abstract Number: 2188 • 2017 ACR/ARHP Annual Meeting

    Risk of Disability in Underweight Persons with or at Increased Risk of Knee Osteoarthritis

    Nilasha Ghosh, Joan S. Chmiel, Orit Almagor, Karen W. Hayes, Kirsten C. Moisio, Alison H. Chang, Julie Szymaszek and Leena Sharma, Northwestern University, Chicago, IL

    Background/Purpose: US studies have revealed a U-shaped relationship between BMI and poor outcomes (function, mortality); both underweight and overweight/obese persons have greater risk. In knee…
  • Abstract Number: 2234 • 2017 ACR/ARHP Annual Meeting

    Disability in Acute Low Back Pain: The Role of Pain Severity, Pain Catastrophizing, Depression, and Exercise

    Elizabeth Salt1, Leslie J. Crofford2, Mary Kay Rayens3 and Suzanne Segerstrom4, 1University of Kentucky, Lexington, KY, 2Medicine, Vanderbilt University Medical Center, Nasville, TN, 3College of Nursing, University of Kentucky, Lexington, KY, 4Psychology, University of Kentucky, Lexington, KY

    Disability in Acute Low Back Pain: The Role of Pain Severity, Pain Catastrophizing, Depression, and ExerciseBackground/Purpose: The effectiveness of cognitive treatments for low back pain,…
  • Abstract Number: 2258 • 2017 ACR/ARHP Annual Meeting

    Real-World Evidence Linking Health-Related Quality of Life to Work Outcomes in Patients with Rheumatoid Arthritis

    Vibeke Strand1, Mark Kosinski2, Regina Rendas-Baum2, David Brooks3 and Rita Ganguly4, 1Division of Immunology/Rheumatology, Stanford University, Stanford, CA, 2Optum, Inc, Eden Prairie, MN, 3GlaxoSmithKline, Philadelphia, PA, 4GlaxoSmithKline, Collegeville, PA

    Background/Purpose: Evaluating health-related quality of life (HRQoL) scores is a key component of the management of rheumatoid arthritis (RA) and evaluation of treatment efficacy.  There…
  • Abstract Number: 550 • 2016 ACR/ARHP Annual Meeting

    Despite Early Improvement and Limited Self-Reported Disability, Patients with Rheumatoid Arthritis Still Have Impaired Grip Strength 5 Years after Diagnosis

    Maria Rydholm1,2, Christina Book1,2, Ingegerd Wikström1,2, Lennart T.H. Jacobsson1,3 and Carl Turesson1,2, 1Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, 3Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden

    Background/Purpose:   Methods:  An inception cohort of patients with Grip force (Newton, N) was measured using the electronic instrument Grippit (AB Detektor, Gothenburg, Sweden). Average…
  • Abstract Number: 552 • 2016 ACR/ARHP Annual Meeting

    Disability in Early Rheumatoid Arthritis, Course and Predictors  

    Therese Hansson1,2, Christina Book1,2, Lennart T.H. Jacobsson1,3 and Carl Turesson1,2, 1Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, 3Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden

    Background/Purpose: Patient reported outcome measures (PROMs), including the Health Assessment Questionnaire Disability Index (HAQ-DI), are valuable and reliable instruments for assessment of disease severity and…
  • Abstract Number: 909 • 2016 ACR/ARHP Annual Meeting

    A “Yellow Card” Reporting System for Sight Loss in Giant Cell Arteritis

    Bhaskar Dasgupta1, Asad Khan1, Dimos Merinopoulos1, Siwalik Banerjee2, Dawn Gayford3, Philip Stapleton1, Faidra Laskou1 and Gianina Statache1, 1Rheumatology, Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea, United Kingdom, 2Rheumatology, Southend University Hospital NHS Foundation Trust, Wescliff-on-Sea, United Kingdom, 3Rheumatology, Southend University Hospital NHS Foundation Trust, westcliff-on-Sea, United Kingdom

    Background/Purpose: It is reported that 15-25% patients with GCA present with visual complications. Sight loss (SL) in the elderly is associated with considerable morbidity. There…
  • Abstract Number: 1541 • 2016 ACR/ARHP Annual Meeting

    Frailty Is Associated with Decreased Physical Function in Adults with Rheumatoid Arthritis

    James Andrews1, Ken Covinsky2, Catherine Hough1, Laura Trupin3, Edward H. Yelin3 and Patricia P. Katz3, 1Medicine, University of Washington, Seattle, WA, 2Medicine, University of California San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Reduced physical function and health-related quality of life remain common in Rheumatoid Arthritis (RA), and further studies are needed that examine potential, novel determinates…
  • Abstract Number: 2208 • 2016 ACR/ARHP Annual Meeting

    Mediators of the Relationship Between Pain and Disability in the Distal Upper Limb

    Daniel Whibley1,2,3, Kathryn Remmes Martin1,2,3, Karina Lovell4, Gareth T. Jones1,2,3 and Arm Pain Trial Investigators, 1Arthritis Research UK / MRC Centre for Musculoskeletal Health and Work, University of Aberdeen, Aberdeen, United Kingdom, 2Aberdeen Centre for Arthritis and Musculoskeletal Health, University of Aberdeen, Aberdeen, United Kingdom, 3Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom, 4School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, United Kingdom

    Background/Purpose: Disabling distal upper limb pain is common but relatively understudied. Fear avoidance (FA) models of disability have been empirically tested for back and lower…
  • Abstract Number: 2218 • 2016 ACR/ARHP Annual Meeting

    Do Some Patients with Distal Upper Limb Pain Benefit More Than Others from Advice to Remain Active?

    Daniel Whibley1,2,3, Kathryn Remmes Martin1,2,3, Karina Lovell4, Gary J. Macfarlane1,2,3, Keith Palmer5,6, David Coggon5,6, Karen Walker-Bone5,6, Kim Burton7, Peter Heine8, Candida McCabe9,10, Paul McNamee11, Alex McConnachie12 and Gareth T. Jones1,2,3, 1Aberdeen Centre for Arthritis and Musculoskeletal Health, University of Aberdeen, Aberdeen, United Kingdom, 2Arthritis Research UK / MRC Centre for Musculoskeletal Health and Work, University of Aberdeen, Aberdeen, United Kingdom, 3Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom, 4School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, United Kingdom, 5MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom, 6University of Southampton, Arthritis Research UK / MRC Centre for Musculoskeletal Health and Work, Southampton, United Kingdom, 7Centre for Health and Social Care Research, University of Huddersfield, Huddersfield, United Kingdom, 8Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom, 9University of West of England, Bristol, Bristol, United Kingdom, 10Royal United Hospitals NHS Foundation Trust, Bath, United Kingdom, 11Health Economics Research Unit, University of Aberdeen, Aberdeen, United Kingdom, 12Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: We have previously shown that, among patients awaiting physiotherapy for distal upper limb pain/disability, advice to remain active is associated with greater functional recovery…
  • Abstract Number: 2540 • 2016 ACR/ARHP Annual Meeting

    The Longitudinal Impact of Biologic Use on Disability within a RA Registry

    N A Shadick1, Nicole Gerlanc2, M Frits1, Bradley S. Stolshek3, Brenna Brady2, Christine Iannaccone4, David Collier5, Jing Cui6, Alex Mutebi7 and Michael Weinblatt4, 1Brigham and Women's Hospital, Boston, MA, 2Health Analytics, LLC, Columbia, MD, 3Amgen, Thousand Oaks, CA, 4Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Amgen Inc., Thousand Oaks, CA, 6Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 7Global Health Economics, Amgen, Thousand Oaks, CA

    Background/Purpose: Biologics have become the standard of care for treating moderate to severe rheumatoid arthritis (RA) in patients with an inadequate response to small molecule…
  • Abstract Number: 2922 • 2016 ACR/ARHP Annual Meeting

    Disability, Fatigue, and Their Associates in Early Diffuse Cutaneous Systemic Sclerosis

    Ariane L. Herrick1, Sébastien Peytrignet2, Xiaoyan Pan3, Roger Hesselstrand4, Luc Mouthon5, László Czirják6, Madelon C. Vonk7, Oliver Distler8, Joerg H.W Distler9, Edith Brown3, Kim Fligelstone3, Rachel Ochiel10, William Gregory11, Alan Silman12, Mark Lunt13 and Christopher Denton14, 1Centre for Musculoskeletal Research, University of Manchester, MAHSC, Salford Royal Hospital, Manchester, United Kingdom, 2Manchester Academic Health Sciences Centre, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 3Manchester Academic Health Science Centre, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 4Department of Rheumatology, Lund University, Lund, Sweden, 5Internal Medicine, Hopital Cochin, Paris, France, 6Department of Rheumatology and Immunology, University of Pécs, Faculty of Medicine, Pécs, Hungary, 7Department of the Rheumatic Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 8Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 9Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany, 10Royal Free London NHS Foundation Trust, London, United Kingdom, 11Rehabilitation Services, Salford Royal NHS Foundation Trust, Salford, United Kingdom, 12Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 13Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, 14Centre for Rheumatology, Royal Free Hospital, London, Great Britain

    Background/Purpose: ESOS (European Scleroderma Observational Study) was a prospective observational study of 326 patients with early diffuse cutaneous systemic sclerosis (dcSSc) from 50 centres. Here…
  • Abstract Number: 25 • 2016 ACR/ARHP Annual Meeting

    Have Outcomes of Patients with Inflammatory Arthritis Improved in the New Millennium? a Comparison of the 10 Year Outcome in Cohorts Recruited in 1990-4 and 2000-4

    James Gwinnutt1, Deborah P.M. Symmons1,2, Alex J Macgregor3,4, Jacqueline Chipping3,4, Tarnya Marshall3,4, Mark Lunt1 and Suzanne M.M. Verstappen1, 1Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, 3Rheumatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom, 4School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, United Kingdom

    Background/Purpose: New treatments have improved the short term outlook for patients with inflammatory polyarthritis (IP) over the past 20 years. However there is limited evidence…
  • Abstract Number: 116 • 2016 ACR/ARHP Annual Meeting

    Racial Differences in Self-Reported Pain and Disability: A Longitudinal Study of Knee Osteoarthritis

    Ernest Vina1, Di Ran2, Erin Ashbeck2 and C. Kent Kwoh3, 1Rheumatology, University of Arizona, Tucson, AZ, 2University of Arizona, Tucson, AZ, 3Rheumatology, University of Arizona, College of Medicine, Tucson, AZ

    Background/Purpose:   Pain and disability from knee osteoarthritis (KOA) has been reported to be greater among African-Americans (AAs) than Whites (WHs), though progression in KOA-related…
  • Abstract Number: 377 • 2016 ACR/ARHP Annual Meeting

    Pain and Quality of Life Profiles in Colombian Patients with Rheumatoid Arthritis: A Mixed Cluster Analysis

    Juan Manuel Cotte1, Nicolás Molano-González2, Deisy Hernández-Parra3, Yenifer Delgado-Scarpetta3, Adriana Rojas-Villarraga2, Juan-Manuel Anaya1 and Ricardo Pineda-Tamayo3, 1Center for Autoimmune Diseases Research (CREA). School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia., Bogotá, Colombia, 2Center for Autoimmune Diseases Research (CREA). School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia., Bogotá D.C., Colombia, 3Artmédica IPS, Medellin, Colombia, Medellin, Colombia

    ABSTRACT Background/Purpose: Among the symptoms of Rheumatoid Arthritis (RA), pain is often regarded as a critical factor related to quality of life (QoL) by patients,…
  • Abstract Number: 395 • 2016 ACR/ARHP Annual Meeting

    The Influence of Early Achievement of “Clinically Inactive Disease” or “Minimal Disease Activity” on Long-Term Disability Outcomes in JIA

    Stephanie J.W.Shoop1,2, Suzanne M.M. Verstappen3, Janet E. McDonagh4, Wendy Thomson5,6, Kimme L. Hyrich3,7 and CAPS, 1Central Manchester University Hospitals NHS Foundation Trust and University of Manchester Partnership, NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester, United Kingdom, 2The University of Manchester, Arthritis Research UK Centre for Epidemiology, Manchester, United Kingdom, 3Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, 4Faculty of Medical and Human Sciences, Centre for MSK Research, Manchester, United Kingdom, 5Arthritis Research UK Centre for Genetics and Genomics,The University of Manchester, Manchester, United Kingdom, 6NIHR Manchester Musculoskeletal Biomedical Research Unit, Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 7Arthritis Research UK, Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Different definitions of clinically inactive disease (CID) for JIA have recently been shown to identify different groups of children. It is unclear whether long-term…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology